Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Changes in the intensified regimen of infliximab in patients with inflammatory bowel disease in sustained remission: Reflections on a series of cases
Laura Gutiérrez-Rios; Eva Vayreda; Margalida Calafat; Fiorella Cañete; Eugeni Domènech; Míriam Mañosa;
Gastroenterol Hepatol. 2024;47:867-8
Incidence of herpes zoster in patients with inflammatory bowel disease
Anna Calm; Margalida Calafat; Carlos González-Muñoza; Fiorella Cañete; Cristina Roig; Míriam Mañosa; Esther Garcia-Planella; Eugeni Domènech;
Gastroenterol Hepatol. 2024;47:598-604
Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission
Gisela Piñero; Míriam Mañosa; Margalida Calafat; Eva Vayreda; Fiorella Cañete; Maria Puig; Eugeni Domènech;
Gastroenterol Hepatol. 2024;47:612-9